Citing a lack of robust, peer-reviewed literature on the efficacy of its own involvement, the agency has cautioned against the methodological risks of prematurely assisting with the crisis.
ATLANTA — While the World Health Organization continues its on-the-ground response to the unfolding hantavirus outbreak, U.S. health officials released a pre-print statement Tuesday suggesting that any sudden deployment of federal resources could introduce dangerous confounding variables into the global health landscape.
Agency researchers noted that while early epidemiological indicators point to a severe public health event, the data remains preliminary. By maintaining a strict, statistically significant distance from the crisis, the Centers for Disease Control and Prevention hopes to establish a pristine control group to evaluate what happens when an outbreak is left entirely to the WHO.
While observational reports indicate the virus is spreading, we must be careful not to introduce the external bias of federal assistance before the natural baseline of the pathogen is established.
Addressing experts who have spent the past week asking where the CDC is, agency epidemiologists warned that “where” is a geographically complex metric that cannot be definitively answered without a larger sample size of similar outbreaks. An internal review board is currently evaluating whether confirming the agency's physical location might inadvertently trigger a placebo effect among affected populations.
According to the disclosure, the CDC has no financial conflicts of interest to report regarding the outbreak, largely because it has not spent any money on it. The agency concluded its briefing by recommending a standard regimen of extreme caution, advising the international medical community against drawing any statistically significant conclusions from the fact that the U.S. government is not currently doing anything.